The Orthopedic Splints market was valued at around US$ 1.5 billion in 2021. With a projected CAGR of 11.5% for the next ten years, the market is likely to reach a valuation of nearly US$ 4.9 billion by the end of 2032. The recent surge in the cases of osteoporosis and the increasing cohort of the geriatric populace has triggered the demand for orthopedic splints.
| Attributes | Details |
|---|---|
| Orthopedic Splints Market Size (2021A) | US$ 1.5 billion |
| Orthopedic Splints Market Size (2022E) | US$ 1.7 billion |
| Projected Market Value (2032F) | US$ 4.9 billion |
| Global Market Growth Rate (2022 to 2032) | 11.5% CAGR |
| North America Market Share (2021) | 35% |
| Key Companies Profiled |
|
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global market for orthopedic splints expanded at a CAGR of 10.6% from 2017 to 2021. The market growth is projected to benefit from the surge in requirements for fiberglass splints. Fiberglass splints are extensively advantageous relative to plaster splints. Aside from weighing less, they are a better option because of their increased durability and porosity.
The global Orthopedic Splints market is predicted to surge ahead at a CAGR of 11.5% and record sales worth US$ 4.9 billion by the end of 2032. USA will continue to be the largest market throughout the analysis period accounting for over US$ 1.1 billion absolute dollar opportunity in the coming 10-year epoch.
The highly accelerated increase in the number of people suffering from musculoskeletal diseases like osteoporosis and arthritis is one of the instrumental driving forces for the demand for Orthopedic Splints during the 10-year forecast epoch. Additionally, the Orthopedic Splints market is also anticipated to be advanced by the increase in the geriatric cohort of the population globally, as it will directly aid in increasing the number of patients having orthopedic ailments leading to a positive impact on the orthopedic splints demand. Taking into account, a 2020 report by the National Natural Science Foundation Council of China, cases of knee osteoarthritis around the world are 16%, which is significantly more in the aged 40 and above population. Factors such as growing sports-related injuries and the increase in the number of road accidents are also anticipated to have an advantageous effect on the Orthopedic Splints market during the forecast period.
Principal Consultant
Compartment syndrome, the creation of pressure sores, and the risk of thermal injuries during the procedure of splinting or casting are among the key growth restraints faced by the Orthopedic Splints market during the forecast period. Moreover, high prices associated with fiberglass splints and the related custom products in some regions around the world may also hamper the growth of the Orthopedic Splints Market during the forecast period. Presently the BSN Medical Articast Fiberglass Casting Tape costs as high as Rs. 1,144 in India. Thus, high costs can be detrimental to the Orthopedic Splints Market.
Asia- Pacific is expected to be the most lucrative region for the Orthopedic Splints Market during the next 10-year epoch owing to the highly accelerated growth it is envisioned to experience. In the recent few years, hip fractures are on a steady rise in Japan, and it is anticipated that hip fractures could go up to 7.3-21.3 million population every year. This is projected to influence the lower extremity segment through the application of the Orthopedic Splints Market in Japan.
A 2018 article by the British Medical Journal states that as many as 135 million Indians are dealing with obesity, which increases the possibility of orthopedic injuries by 48%. As per a NIC report, as many as 467,044 street accidents have been reported in India in 2018 which lead to fractures and related injuries fueling the demand for orthopedic splints in both upper and lower extremities. Moreover, another article by the National Institute of Health and Family (NIHFW), by the Ministry of Health and Welfare (MoHFW) states that not only osteoarthritis is the second most common rheumatologic issue, but it also had a prevalence of 22%-39% in 2018 in the country. All these factors are contributing to the growth of the Orthopedic Splints Market in the country. Since the rise in cases of orthopedic diseases such as osteoarthritis is increasing, it will directly affect the application of orthopedic splints, thereby benefitting the market. The market in the region is further benefitted by the expanding medical tourism, especially to the countries such as India and China due to their comparative cost-effectiveness and availability of high-order equipment.
Orthopedic Splints Market in the North American region accounts for more than 35% of the total market revenue and is projected to keep its dominant position in the market intact during the 10-year forecast period. The USA is forecasted to dominate the Orthopedic Splints Market in the North-American region. Taking into account the World Population Aging Report, people over the age of 65 in the USA and Canada are anticipated to increase from over 60 million in 2019 to approximately 80 million in 2030. Considering the elevated vulnerability of this cohort to arthritis, joint pain, and other related orthopedic conditions, it is anticipated to be instrumental to fuel the growth of the Orthopedic Splints Market forward during the forecasted period of 10 years in the North American region. Additionally, the Orthopedic Splints Market is expected to gain further traction in the North American region from the increasing Sports injuries in the USA The American Academy of Pediatrics reported in a 2019 article that among all the time-loss injuries among soccer players aged 5-17, the most common are ankles and knees, with 20.9% and 16.3% of the total injuries, respectively. Due to this, the demand for orthopedic splints in the lower extremity segment by application is projected to increase during the forecast period, thus positively shaping the market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
During the forthcoming years, the USA is expected to experience a US$ 1.1 billion absolute dollar opportunity to grow at a highly accelerated rate of 12.4% CAGR and reach the market valuation of US$ 1.6 billion by the end of 2032. Centers for Disease Control and Prevention (CDC) estimates that approximately 78 million (26% of the adults in the USA) will be suffering from arthritis by 2040. This increasing volume is set to further fuel the Orthopedic Splints Market during the forecast years.
A recent article by the National Center for Biotechnology Information (NCBI) states that in 2020, approximately 1.5 million people have suffered from fractures related to bone disorders. With as many as 3.5 million annual sports injuries among teens and children in the USA, the demand for orthopedic splints is expected to be benefitted during the forecast period of 10 years due to this, leading to an increase in its application. Thus, the USA is expected to play an instrumental role in the Global Orthopedic Splints Demand in the forthcoming years.
In 2020, around 470,000 workers suffered from work-related musculoskeletal disorders. Considering the overall population, around 20.3 million people in the United Kingdom have musculoskeletal (MSK) conditions such as arthritis or back pain. Apart from this, a large population in the country has been suffering from shin splints. Owing to these facts, the market in the United Kingdom is projected to reach a valuation of US$ 225 million by 2032, growing at a CAGR of 12.4%.
Japan is one of the countries with a high geriatric population. This has kept the Japanese people exposed to several orthopedic ailments. There were nearly 5,000 general hospitals in Japan with orthopedic surgery departments. With these statistics, the orthopedic splints market in Japan is expected to reach a valuation of US$ 194 million by 2032, growing at a CAGR of 11.5% from 2022 to 2032.
A total of 735,073 ankle fractures were identified in 461,497,758 South Korean people in the last 10 years. The annual incidence of ankle fracture was 171.4 per 100,000 persons, with a male-to-female ratio of 0.78. With these statistics, the orthopedic splints market in South Korea is projected to garner an absolute dollar opportunity of US$ 89.2 million, from 2022 to 2032.
Orthopedic Splints market revenue through the lower extremity segment is projected to witness a CAGR of 10.3% during the 10-year epoch. The 2017 statistics of the International Osteoporosis Foundation stated that annually around 8.9 million fractures globally are the result of osteoporosis. This consequently leads to an osteoporosis fracture, every 3 seconds. Over 86% of hip fractures globally occur among the geriatric population. United Nations’ World Population Ageing report of 2019, states that as of 2019, 703 million of the global population is 65 or above. This number is projected to rise to approximately 1.5 billion by 2050. These factors are anticipated to raise the demand for Orthopedic Splints by augmenting their necessity in the Lower Extremity segment during the forecast period.
3M Company, DeRoyal Industries Inc., BSN Medical, Zimmer Biomet Holdings Inc., Medi GmbH & Co. KG, Orthosys, Breg Inc. (Orthofyx), United Medicare, Sam Medical, Essity, Stryker Corporation, DeRoyal Industries Inc., and Ottobock SE & Co. KGaA are among the key players driving the competitive landscape of the market. To expand their product portfolio and simultaneously capitalize on the growing market demand, many of these companies are adopting strategies such as mergers, acquisitions, and partnerships.
Recent Developments
The Orthopedic Splints Market is segmented based on application, product type, end-user, and region.
The Orthopedic Splints market was valued at US$ 1.5 billion in 2021.
The Orthopedic Splints industry is set to witness a growth rate of over 11.5% during the forecast period and be valued at US$ 4.9 billion by 2032.
3M Company, DeRoyal Industries Inc., BSN Medical, Zimmer Biomet Holdings Inc., Medi GmbH & Co. KG, Orthosys, Breg Inc. (Orthofyx), United Medicare, Sam Medical, Essity, Stryker Corporation, DeRoyal Industries Inc., and Ottobock SE & Co. KGaA are among the key players shaping the Orthopedic Splints Industry.
The augmented requirement of orthopedic splints in the lower extremity application due to growing cases of arthritis and other related orthopedic ailments is anticipated to favorably impact the global demand over the forecast period.
The market in the USA is expected to reach a valuation of US$ 1.6 billion by 2032, with a CAGR of 12.4%.
The Asia Pacific market is expected to grow significantly during the forecast period mainly due to the increasing geriatric population leading to a subsequent expansion of the cases of osteoarthritis.
1. Executive Summary | Orthopedic Splints Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.6. Investment Feasibility Matrix 3.7. PESTLE and Porter’s Analysis 3.8. Regulatory Landscape 3.8.1. By Key Regions 3.8.2. By Key Countries 4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032 4.1. Historical Market Size Value (US$ million) Analysis, 2017 to 2021 4.2. Current and Future Market Size Value (US$ million) Projections, 2022 to 2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ million) Analysis By Product Type, 2017 to 2021 5.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Product Type, 2022 to 2032 5.3.1. Plaster Splints 5.3.2. Fiberglass Splints 5.3.3. Tools & Accessories 5.3.4. Other Product Types 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2021 5.5. Absolute $ Opportunity Analysis By Product Type, 2022 to 2032 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ million) Analysis By Application, 2017 to 2021 6.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Application, 2022 to 2032 6.3.1. Upper Extremity 6.3.1.1. Elbow 6.3.1.2. Hand & Wrist 6.3.1.3. Shoulder 6.3.1.4. Neck 6.3.2. Lower Extremity 6.3.2.1. Hip 6.3.2.2. Knee 6.3.2.3. Ankle & Foot 6.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2021 6.5. Absolute $ Opportunity Analysis By Application, 2022 to 2032 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End-user 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ million) Analysis By End-user, 2017 to 2021 7.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By End-user, 2022 to 2032 7.3.1. Specialty Centers 7.3.2. Hospitals 7.3.3. Other End-users 7.4. Y-o-Y Growth Trend Analysis By End-user, 2017 to 2021 7.5. Absolute $ Opportunity Analysis By End-user, 2022 to 2032 8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ million) Analysis By Region, 2017 to 2021 8.3. Current Market Size Value (US$ million) Analysis and Forecast By Region, 2022 to 2032 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. East Asia 8.3.5. South Asia 8.3.6. Oceania 8.3.7. Middle East and Africa (MEA) 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 9.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021 9.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032 9.2.1. By Country 9.2.1.1. The USA 9.2.1.2. Canada 9.2.2. By Product Type 9.2.3. By Application 9.2.4. By End-user 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product Type 9.3.3. By Application 9.3.4. By End-user 9.4. Key Takeaways 10. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 10.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021 10.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Argentina 10.2.1.4. Chile 10.2.1.5. Peru 10.2.1.6. Rest of Latin America 10.2.2. By Product Type 10.2.3. By Application 10.2.4. By End-user 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Application 10.3.4. By End-user 10.4. Key Takeaways 11. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 11.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021 11.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. Italy 11.2.1.3. France 11.2.1.4. The United Kingdom 11.2.1.5. Spain 11.2.1.6. Russia 11.2.1.7. BENELUX 11.2.1.8. Rest of Europe 11.2.2. By Product Type 11.2.3. By Application 11.2.4. By End-user 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Application 11.3.4. By End-user 11.4. Key Takeaways 12. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 12.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021 12.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.2. By Product Type 12.2.3. By Application 12.2.4. By End-user 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Application 12.3.4. By End-user 12.4. Key Takeaways 13. South Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 13.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021 13.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Thailand 13.2.1.3. Malaysia 13.2.1.4. Indonesia 13.2.1.5. Rest of South Asia 13.2.2. By Product Type 13.2.3. By Application 13.2.4. By End-user 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Application 13.3.4. By End-user 13.4. Key Takeaways 14. Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 14.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021 14.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032 14.2.1. By Country 14.2.1.1. Australia 14.2.1.2. New Zealand 14.2.2. By Product Type 14.2.3. By Application 14.2.4. By End-user 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product Type 14.3.3. By Application 14.3.4. By End-user 14.4. Key Takeaways 15. MEA Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 15.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021 15.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. Rest of MEA 15.2.2. By Product Type 15.2.3. By Application 15.2.4. By End-user 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product Type 15.3.3. By Application 15.3.4. By End-user 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. The USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2021 16.1.2.1. By Product Type 16.1.2.2. By Application 16.1.2.3. By End-user 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2021 16.2.2.1. By Product Type 16.2.2.2. By Application 16.2.2.3. By End-user 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2021 16.3.2.1. By Product Type 16.3.2.2. By Application 16.3.2.3. By End-user 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2021 16.4.2.1. By Product Type 16.4.2.2. By Application 16.4.2.3. By End-user 16.5. Argentina 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2021 16.5.2.1. By Product Type 16.5.2.2. By Application 16.5.2.3. By End-user 16.6. Germany 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2021 16.6.2.1. By Product Type 16.6.2.2. By Application 16.6.2.3. By End-user 16.7. Italy 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2021 16.7.2.1. By Product Type 16.7.2.2. By Application 16.7.2.3. By End-user 16.8. France 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2021 16.8.2.1. By Product Type 16.8.2.2. By Application 16.8.2.3. By End-user 16.9. The United Kingdom 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2021 16.9.2.1. By Product Type 16.9.2.2. By Application 16.9.2.3. By End-user 16.10. Spain 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2021 16.10.2.1. By Product Type 16.10.2.2. By Application 16.10.2.3. By End-user 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2021 16.11.2.1. By Product Type 16.11.2.2. By Application 16.11.2.3. By End-user 16.12. BENELUX 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2021 16.12.2.1. By Product Type 16.12.2.2. By Application 16.12.2.3. By End-user 16.13. China 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2021 16.13.2.1. By Product Type 16.13.2.2. By Application 16.13.2.3. By End-user 16.14. Japan 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2021 16.14.2.1. By Product Type 16.14.2.2. By Application 16.14.2.3. By End-user 16.15. South Korea 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2021 16.15.2.1. By Product Type 16.15.2.2. By Application 16.15.2.3. By End-user 16.16. India 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2021 16.16.2.1. By Product Type 16.16.2.2. By Application 16.16.2.3. By End-user 16.17. Thailand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2021 16.17.2.1. By Product Type 16.17.2.2. By Application 16.17.2.3. By End-user 16.18. Malaysia 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2021 16.18.2.1. By Product Type 16.18.2.2. By Application 16.18.2.3. By End-user 16.19. Indonesia 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2021 16.19.2.1. By Product Type 16.19.2.2. By Application 16.19.2.3. By End-user 16.20. Australia 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2021 16.20.2.1. By Product Type 16.20.2.2. By Application 16.20.2.3. By End-user 16.21. New Zealand 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2021 16.21.2.1. By Product Type 16.21.2.2. By Application 16.21.2.3. By End-user 16.22. GCC Countries 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2021 16.22.2.1. By Product Type 16.22.2.2. By Application 16.22.2.3. By End-user 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Product Type 17.3.3. By Application 17.3.4. By End-user 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. 3M Company 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments (Product/Region) 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.1.5.2. Product Strategy 18.1.1.5.3. Channel Strategy 18.1.2. DeRoyal Industries Inc. 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments (Product/Region) 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.2.5.2. Product Strategy 18.1.2.5.3. Channel Strategy 18.1.3. Zimmer Biomet Holdings Inc. 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments (Product/Region) 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.3.5.2. Product Strategy 18.1.3.5.3. Channel Strategy 18.1.4. Medi GmbH & Co. KG 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments (Product/Region) 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.4.5.2. Product Strategy 18.1.4.5.3. Channel Strategy 18.1.5. Orthosys 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments (Product/Region) 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.5.5.2. Product Strategy 18.1.5.5.3. Channel Strategy 18.1.6. Value (US$ million)ed Medicare 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments (Product/Region) 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.6.5.2. Product Strategy 18.1.6.5.3. Channel Strategy 18.1.7. Sam Medical 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments (Product/Region) 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.7.5.2. Product Strategy 18.1.7.5.3. Channel Strategy 18.1.8. BSN Medical 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments (Product/Region) 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.8.5.2. Product Strategy 18.1.8.5.3. Channel Strategy 18.1.9. Essity 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments (Product/Region) 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.9.5.2. Product Strategy 18.1.9.5.3. Channel Strategy 18.1.10. Stryker Corporation 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments (Product/Region) 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.10.5.2. Product Strategy 18.1.10.5.3. Channel Strategy 18.1.11. DeRoyal Industries Inc. 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments (Product/Region) 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 18.1.11.5.2. Product Strategy 18.1.11.5.3. Channel Strategy 18.1.12. Ottobock SE & Co. KGaA 18.1.12.1. Overview 18.1.12.2. Product Portfolio 18.1.12.3. Profitability by Market Segments (Product/Region) 18.1.12.4. Sales Footprint 18.1.12.5. Strategy Overview 18.1.12.5.1. Marketing Strategy 18.1.12.5.2. Product Strategy 18.1.12.5.3. Channel Strategy 18.1.13. Breg Inc. 18.1.13.1. Overview 18.1.13.2. Product Portfolio 18.1.13.3. Profitability by Market Segments (Product/Region) 18.1.13.4. Sales Footprint 18.1.13.5. Strategy Overview 18.1.13.5.1. Marketing Strategy 18.1.13.5.2. Product Strategy 18.1.13.5.3. Channel Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Orthopedic Splints Market
